Published in Kidney Int Suppl (2011) on December 01, 2013
Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype. Kidney Int (2015) 0.89
Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers (2015) 0.82
Vitamin D deficiency may predict a poorer outcome of IgA nephropathy. BMC Nephrol (2016) 0.78
Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study. BMC Nephrol (2015) 0.75
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol (2007) 4.59
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10
Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA (2013) 2.98
IOF position statement: vitamin D recommendations for older adults. Osteoporos Int (2010) 2.79
Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol (2006) 2.54
Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int (2008) 2.38
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int (2008) 2.28
Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res (2003) 2.05
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab (2006) 1.91
Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol (2013) 1.78
Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate. Kidney Int (2010) 1.77
The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab (2010) 1.42
Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol (2012) 1.41
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant (2010) 1.29
Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int (2011) 1.24
Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol (2011) 1.20
Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res (2012) 1.18
Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol (2012) 1.16
FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy. Clin J Am Soc Nephrol (2012) 1.09
The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract (1990) 1.06
Soluble klotho and autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 1.00
Vitamin D status and outcomes after renal transplantation. J Am Soc Nephrol (2013) 0.97
Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease. Nephrol Dial Transplant (2012) 0.95
Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies. Clin Chim Acta (2011) 0.90
Serum 25-hydroxyvitamin d concentrations and season-specific correlates in Japanese adults. J Epidemiol (2011) 0.86
Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan. Ther Apher Dial (2011) 0.85